Zelanna Goldberg, MD
Dr. Zelanna Goldberg, the Chief Medical Officer at Replicate Bio science, is a radiation oncologist with over 20 years’ experience in drug development and industry leadership. Before joining Replicate, she was Chief Medical Officer at Alpine Immune Sciences and, before Alpine, she was Senior Vice President of Clinical Development at Iovance Bio therapeutics leading development programs in non-small-cell lung cancers, head and neck cancers, and combination strategies. Prior to Iovance, she spent nearly nine years in Global Development at Pfizer, where she held positions of increasing responsibility leading programs from pre-IND to NDA/BLA, including leading global phase 3 registrational studies. Dr. Goldberg co-developed the Master of Science in Drug Development Program at the University of California San Diego (UCSD), and before joining industry was an associate professor at the University of California Davis.